# TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults

> **NCT06749587** · NA · RECRUITING · sponsor: **Teoxane SA** · enrollment: 260 (estimated)

## Conditions studied

- Infraorbital Hollows

## Interventions

- **DEVICE:** TEOSYAL RHA® 1

## Key facts

- **NCT ID:** NCT06749587
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2025-03-12
- **Final completion:** 2026-01-12
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06749587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06749587, "TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06749587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*